Novo’s oral amycretin could lead to more weight loss beyond 12 weeks, according to early-stage trial

No­var­tis is sell­ing off its mol­e­c­u­lar imag­ing busi­ness for positron emis­sion to­mog­ra­phy (PET) scans to Siemens Health­i­neers for an undis­closed amount, both com­pa­nies con­firmed to

NATIONAL HARBOR, Md. — More than two-thirds of nulliparous women achieved vaginal delivery after outpatient induction of labor (IOL), the HOME INDUCTION randomized noninferiority trial